Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

Novo Nordisk's stock (NVO ... product delivered favorable results. The new drug, amycretin, similar to the company's blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, provided ...

This is the best news Novo Nordisk has been able to report in more than a month. Twice in the past two months, the Danish manufacturer of GLP-1 drugs for weight loss and diabetes treatment has ...

Novo Nordisk has been one of ... Novo’s main obesity offering, and diabetes treatment Ozempic have soared in popularity and been touted as “miracle drugs” for their startling efficacy ...